# AGNC Investment Corp.: financial statements, quarterly

AGNC · Nasdaq · CIK 1423689 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/agnc.md) · [Financials](/companies/agnc/financials.md) · [Filings](/companies/agnc/filings.md) · [Insiders](/companies/agnc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/agnc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [666 d](/filings/0001423689-24-000005.md) | [672](/filings/0001423689-24-000039.md) | [698](/filings/0001423689-24-000058.md) | [820](/filings/0001423689-24-000076.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $m | [749](/filings/0001423689-24-000005.md) | [443](/filings/0001423689-25-000056.md) | [(48.0)](/filings/0001423689-25-000073.md) | [346](/filings/0001423689-25-000106.md) | [122 d](/filings/0001423689-26-000043.md) | [50.0](/filings/0001423689-26-000099.md) | [(140)](/filings/0001423689-26-000128.md) | [806](/filings/0001423689-26-000148.md) | [954 d](/filings/0001423689-26-000043.md) | [(148)](/filings/0001423689-26-000099.md) | [654](/filings/0001423689-26-000128.md) | [(1,357)](/filings/0001423689-26-000148.md) |
| Diluted EPS | $ per share | not reported | [0.59](/filings/0001423689-25-000056.md) | [(0.11)](/filings/0001423689-25-000073.md) | [0.39](/filings/0001423689-25-000106.md) | not reported | [0.02](/filings/0001423689-26-000099.md) | [(0.17)](/filings/0001423689-26-000128.md) | [0.72](/filings/0001423689-26-000148.md) | not reported | [(0.17)](/filings/0001423689-26-000099.md) | [0.52](/filings/0001423689-26-000128.md) | [(1.17)](/filings/0001423689-26-000148.md) |
| Basic EPS | $ per share | not reported | [0.59](/filings/0001423689-25-000056.md) | [(0.11)](/filings/0001423689-25-000073.md) | [0.39](/filings/0001423689-25-000106.md) | not reported | [0.02](/filings/0001423689-26-000099.md) | [(0.17)](/filings/0001423689-26-000128.md) | [0.73](/filings/0001423689-26-000148.md) | not reported | [(0.17)](/filings/0001423689-26-000099.md) | [0.53](/filings/0001423689-26-000128.md) | [(1.17)](/filings/0001423689-26-000148.md) |

- Interest expense: us-gaap:InterestExpense
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.5](/filings/0001423689-26-000043.md) | [0.5](/filings/0001423689-25-000056.md) | [0.5](/filings/0001423689-25-000073.md) | [0.5](/filings/0001423689-25-000106.md) | [0.5](/filings/0001423689-26-000043.md) | [0.5](/filings/0001423689-26-000099.md) | [0.7](/filings/0001423689-26-000128.md) | [0.5](/filings/0001423689-26-000148.md) | [0.5](/filings/0001423689-26-000148.md) | [0.5](/filings/0001423689-26-000099.md) | [0.5](/filings/0001423689-26-000128.md) | [0.5](/filings/0001423689-26-000148.md) |
| Total assets | $bn | [71.6](/filings/0001423689-25-000007.md) | [71.9](/filings/0001423689-24-000039.md) | [79.7](/filings/0001423689-24-000058.md) | [89.6](/filings/0001423689-24-000076.md) | [88.0](/filings/0001423689-26-000043.md) | [95.9](/filings/0001423689-25-000056.md) | [102](/filings/0001423689-25-000073.md) | [109](/filings/0001423689-25-000106.md) | [115](/filings/0001423689-26-000148.md) | [119](/filings/0001423689-26-000099.md) | [122](/filings/0001423689-26-000128.md) | [133](/filings/0001423689-26-000148.md) |
| Total liabilities | $bn | [63.3](/filings/0001423689-25-000007.md) | [63.3](/filings/0001423689-24-000039.md) | [71.0](/filings/0001423689-24-000058.md) | [79.9](/filings/0001423689-24-000076.md) | [78.3](/filings/0001423689-26-000043.md) | [85.8](/filings/0001423689-25-000056.md) | [91.7](/filings/0001423689-25-000073.md) | [97.5](/filings/0001423689-25-000106.md) | [103](/filings/0001423689-26-000148.md) | [107](/filings/0001423689-26-000099.md) | [109](/filings/0001423689-26-000128.md) | [122](/filings/0001423689-26-000148.md) |
| Shareholders' equity | $bn | [8.3](/filings/0001423689-26-000043.md) | [8.6](/filings/0001423689-25-000073.md) | [8.7](/filings/0001423689-25-000106.md) | [9.7](/filings/0001423689-25-000106.md) | [9.8](/filings/0001423689-26-000148.md) | [10.0](/filings/0001423689-26-000128.md) | [10.3](/filings/0001423689-26-000148.md) | [11.4](/filings/0001423689-26-000148.md) | [12.4](/filings/0001423689-26-000148.md) | [12.2](/filings/0001423689-26-000128.md) | [12.5](/filings/0001423689-26-000148.md) | [11.6](/filings/0001423689-26-000148.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(31.0) d](/filings/0001423689-26-000043.md) | [20.0](/filings/0001423689-25-000056.md) | [(20.0) d](/filings/0001423689-25-000073.md) | [7.0 d](/filings/0001423689-25-000106.md) | [79.0 d](/filings/0001423689-26-000043.md) | [192](/filings/0001423689-26-000099.md) | [180 d](/filings/0001423689-26-000128.md) | [153 d](/filings/0001423689-26-000148.md) | [128 d](/filings/0001423689-26-000043.md) | [387](/filings/0001423689-26-000099.md) | [218 d](/filings/0001423689-26-000128.md) | [404 d](/filings/0001423689-26-000148.md) |
| Dividends paid | $m | [272 d](/filings/0001423689-26-000043.md) | [282](/filings/0001423689-25-000056.md) | [293 d](/filings/0001423689-25-000073.md) | [318 d](/filings/0001423689-25-000106.md) | [348 d](/filings/0001423689-26-000043.md) | [363](/filings/0001423689-26-000099.md) | [394 d](/filings/0001423689-26-000128.md) | [416 d](/filings/0001423689-26-000148.md) | [428 d](/filings/0001423689-26-000043.md) | [451](/filings/0001423689-26-000099.md) | [458 d](/filings/0001423689-26-000128.md) | [471 d](/filings/0001423689-26-000148.md) |
| Share repurchases | $m | [0.0 d](/filings/0001423689-25-000007.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [579](/filings/0001423689-24-000039.md) | [600](/filings/0001423689-24-000058.md) | [622](/filings/0001423689-24-000076.md) | [704](/filings/0001423689-25-000056.md) | [740](/filings/0001423689-25-000073.md) | [810](/filings/0001423689-25-000106.md) | [922](/filings/0001423689-26-000099.md) | [1,017](/filings/0001423689-26-000128.md) | [1,057](/filings/0001423689-26-000148.md) | [1,123](/filings/0001423689-26-000099.md) | [1,162](/filings/0001423689-26-000128.md) | [1,201](/filings/0001423689-26-000148.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 1,273,805,642 at 2026-10-28, from the cover of the [10-Q filed 2026-10-29](/filings/0001423689-26-000148.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 16:58 ET. No prices; not investment advice.